Valuation: China Isotope & Radiation Corporation

Market Cap 3.15B 3.7B 472M 422M 391M 354M 662M 44.92B 673M 4.7B 1.86B 23.5B 1.77B 1.73B 74.39B P/E 2024
8.03x
P/E 2025 17.7x
Enterprise Value 3.27B 3.84B 490M 438M 405M 367M 687M 46.62B 698M 4.88B 1.93B 24.38B 1.84B 1.8B 77.2B EV / Sales 2024
0.42x
EV / Sales 2025 0.82x
Free-Float
91.44%
Yield 2024
3.74%
Yield 2025 1.69%
10-22 China Isotope & Radiation to Issue New Shares in Subsidiary; Shares Fall 4% MT
10-22 China Isotope & Radiation Declares Interim Dividend MT
10-21 China Isotope & Radiation Corporation Approves Appointment of Li Penghui as Executive Director, Effective 21 October 2026 CI
10-21 China Isotope & Radiation Corporation Approves Interim Dividend for the Six Months Ended 30 June 2026, Payable Before 18 December 2026 CI
10-12 CIRC Unit's H. Pylori Breath Test Kit Wins China Drug Registration Approval MT
09-23 China Isotope & Radiation Unit's Lu-177 API Filing Clears US FDA Review MT
08-28 China Isotope & Radiation Corporation Reports Earnings Results for the Half Year Ended June 30, 2026 CI
08-28 China Isotope & Radiation Corporation Proposes Interim Dividend for the Six Months Ended 30 June 2026, Payable on 18 December 2026 CI
08-28 China Isotope & Radiation Corporation Announces Resignation of Zhang Junqi as an Executive Director, A Member of the Strategy Committee of the Board and A Member of the Science and Technology Innovation Committee of the Board, Effective August 28, 2026 CI
08-28 China Isotope & Radiation Corporation Announces CEO Changes, Effective August 28, 2026 CI
07-06 China Isotope to Form JV With Associate MT
07-03 China Isotope & Radiation Corporation and CNNC Yuanke Enter into Shareholders? Agreement to Establish Joint Venture Company CNNC Fuyuan CI
06-18 China Isotope & Radiation Corporation Approves Final Dividend for the Year Ended 31 December 2025, Payable on Before 17 August 2026 CI
1 day-3.50%
1 week-5.00%
Current month-11.87%
1 month-14.85%
3 months-29.65%
6 months-38.50%
Current year-42.67%
1 week 11
Extreme 11
12.8
1 month 11
Extreme 11
13.79
Current year 11
Extreme 11
24.28
1 year 11
Extreme 11
25
3 years 9.03
Extreme 9.03
25
5 years 9.03
Extreme 9.03
26.5
10 years 9.03
Extreme 9.03
35.4
Manager TitleAgeSince
Chief Executive Officer 54 28/08/2026
Corporate Secretary - 30/08/2024
Corporate Secretary - 30/08/2024
Director TitleAgeSince
Director/Board Member 57 22/02/2017
Director/Board Member 54 28/06/2019
Director/Board Member 54 30/12/2019
Change 5-day change 1-year change 3-year change Capi.($)
-3.50%-5.00%-33.14%-3.50% 489M
+1.14%+0.79%-17.53%+11.60% 179B
-0.33%+2.75%-20.22%+18.39% 118B
-0.65%+2.18%+0.70%+34.70% 117B
-3.42%+13.34%-44.16%+3.81% 93.26B
-0.30%-2.94%-1.80%+74.97% 63.16B
+0.04%+1.79%+13.52%+75.53% 55.68B
-1.27%+2.96%+5.00%-22.74% 54.18B
+1.75%+2.59%-11.92%+43.47% 44.15B
+0.03%+5.88%-5.17%-10.31% 33.95B
Average -0.92%+2.80%-11.47%+22.59% 75.89B
Weighted average by Cap. -0.54%+3.05%-12.35%+23.63%

Financials

2024 2025
Net sales 7.57B 8.91B 1.14B 1.02B 939M 850M 1.59B 108B 1.62B 11.3B 4.47B 56.49B 4.26B 4.17B 179B 7.19B 8.45B 1.08B 963M 891M 807M 1.51B 102B 1.53B 10.72B 4.24B 53.61B 4.04B 3.96B 170B
Net income 407M 478M 60.95M 54.5M 50.42M 45.65M 85.44M 5.8B 86.84M 607M 240M 3.03B 229M 224M 9.6B 327M 385M 49.07M 43.88M 40.6M 36.76M 68.8M 4.67B 69.92M 489M 193M 2.44B 184M 180M 7.73B
Net Debt -109M -128M -16.33M -14.6M -13.51M -12.23M -22.89M -1.55B -23.26M -163M -64.29M -812M -61.27M -59.97M -2.57B 119M 140M 17.81M 15.93M 14.73M 13.34M 24.97M 1.69B 25.38M 177M 70.14M 886M 66.85M 65.42M 2.81B
Projected Income Statement - Annual - China Isotope & Radiation Corporation
Logo China Isotope & Radiation Corporation
China Isotope & Radiation Corp is a China-based company mainly engaged in the research, development, manufacturing and sale of diagnostic and therapeutic radiopharmaceuticals and radioactive source products. The Company operates five business segments. Pharmaceuticals segment is engaged in providing imaging diagnostic and therapeutic radiopharmaceuticals, urea breath test (UBT) kits and analyzers and in vitro diagnostic reagents and kits. Radioactive Source Products segment is engaged in providing various medical and industrial radioactive sources products as well as provision of related technical services. Irradiation segment is engaged in providing sterilization services. Radiation Therapy Equipment and Related Services segment is engaged in manufacturing Radiation therapy equipment. Other Businesses segment is engaged in providing trade services in relation to imported radioactive source, medical nuclides, imported radiopharmaceuticals, and other products.
Employees
3,655
Date Price Change Volume
26/10/26 HK$11.58 -3.50% 367,600
23/10/26 HK$12.00 +1.69% 57,200
22/10/26 HK$11.80 -2.96% 365,000
21/10/26 HK$12.16 +1.50% 50,400
20/10/26 HK$11.98 -1.72% 126,600

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - China Isotope & Radiation Corporation
  1. Stock Market
  2. Stocks
  3. 1763 Stock